Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | FAAH | O00519 | 7/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
| ▸ | AURKA | O14965 | 1/20 | 0.54 |
| ▸ | JAK2 | O60674 | 1/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1041931 | 0.84 | FAAH (0.58) | SMYD3FAAHCNR2HDAC3HDAC4 | |
| SCHEMBL13442787 | 0.83 | FAAH (0.57) | SMYD3FAAHCNR2HDAC3HDAC4 | |
| SCHEMBL1430412 | 0.83 | FAAH (0.57) | SMYD3KDM4EFAAHCNR2AURKA | |
| SCHEMBL1221009 | 0.82 | HDAC3 (0.58) | SMYD3KDM4EFAAHCNR2HDAC3 | |
| SCHEMBL24450206 | 0.82 | HDAC3 (0.58) | SMYD3FAAHCNR2HDAC3HDAC4 | |
| SCHEMBL3668290 | 0.81 | FAAH (0.59) | SMYD3FAAHCNR2AURKAJAK2 | |
| SCHEMBL4307360 | 0.81 | EGLN1 (0.67) | SMYD3FAAHCNR2HDAC3HDAC1 | |
| SCHEMBL9402411 | 0.81 | FAAH (0.52) | SMYD3FAAHCNR2HDAC3HDAC4 | |
| SCHEMBL4069991 | 0.81 | LMNA (0.57) | SMYD3FAAHCNR2HDAC3HDAC4 | |
| SCHEMBL828618 | 0.80 | AURKA (0.59) | KDM4EFAAHAURKAJAK2ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111375784-B | Method for preparing stable nano-silver gel | 宁夏师范学院 | 2022-07-12 | — | — | CN | claimed |
| CN-111375784-A | Method for preparing stable nano-silver gel | 宁夏师范学院 | 2020-07-07 | — | — | CN | claimed |
| CN-110156708-B | Substituted heterocyclic compound containing acylhydrazone skeleton and preparation method and application thereof | 中国药科大学 | 2022-08-09 | — | — | CN | disclosed |
| CN-111375784-B | Method for preparing stable nano-silver gel | 宁夏师范学院 | 2022-07-12 | — | — | CN | disclosed |
| CN-111375784-B | Method for preparing stable nano-silver gel | 宁夏师范学院 | 2022-07-12 | — | — | CN | disclosed |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | NORTHERN ILLINOIS RESEARCH FOUNDATION (US) | 2021-06-08 | — | — | US | disclosed |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | NORTHERN ILLINOIS RESEARCH FOUNDATION (US) | 2021-06-08 | — | — | US | disclosed |
| CN-111375784-A | Method for preparing stable nano-silver gel | 宁夏师范学院 | 2020-07-07 | — | — | CN | disclosed |
| CN-111375784-A | Method for preparing stable nano-silver gel | 宁夏师范学院 | 2020-07-07 | — | — | CN | disclosed |
| US-20180271098-A1 | OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-09-27 | — | — | US | disclosed |
| US-6495545-B1 | ANTIOSTEOPOROTIC, ANTIRESTENOTIC, ANTICARCINOGENIC AND ANTIATHEROSCLEROTIC ACTIVITY | BAYER AKTIENGESELLSCHAFT (DE) | 2002-12-17 | — | — | US | disclosed |
| US-6339083-B1 | FOR THERAPY OF OSTEOPOROSIS, RESTENOSIS, CARCINOSES AND/OR ARTERIOSCLEROSIS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-01-15 | — | — | US | disclosed |
| EP-1140927-A1 | 1,4-BENZODIAZEPINONE DERIVATIVES AND THEIR USE AS INTEGRIN ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035917-A1 | 1,4-BENZODIAZEPINONE DERIVATIVES AND THEIR USE AS INTEGRIN ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-06-22 | — | — | WO | disclosed |
| US-3951920-A | Permselective polymeric membrane prepared from polybenzimidazoles | TEIJIN LIMITED (JA) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180271098-A1 | OXADIAZOLE AND PHENOL DERIVATIVES AS ANTIBACTERIAL AND/OR HERBICIDAL AGENTS | CMPK1, IPMK, ITPA | SMYD3 2114/4885KDM4E 276/4885FAAH 3342/4885 |
| US-11026426-B2 | Oxadiazole and phenol derivatives as antibacterial and/or herbicidal agents | CBR3, AOC3, AHR | SMYD3 1531/4885KDM4E 2652/4885FAAH 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.